Late Lumen Loss (LLL)
Showing 1 - 25 of >10,000
Percutaneous Coronary Intervention (PCI), Coronary Artery Disease (CAD), De Novo Stenosis Trial in Tunis (DEB for de Novo
Recruiting
- Percutaneous Coronary Intervention (PCI)
- +2 more
- DEB for de Novo Lesions
- DES for de Novo Lesions
-
Tunis, TunisiaMilitary hospital of Tunis
Aug 23, 2022
Coronary Heart Disease Trial in Beijing (drug-coated balloon)
Recruiting
- Coronary Heart Disease
- drug-coated balloon
-
Beijing, Beijing, ChinaBeijing Hospital
Sep 25, 2022
Coronary Artery Disease Trial in Shanghai (BuMA Supreme, BuMA™)
Active, not recruiting
- Coronary Artery Disease
- BuMA Supreme
- BuMA™
-
Shanghai, ChinaZhongshan Hospital
Sep 10, 2021
Coronary Artery Disease Trial in Antwerp, Milan (Percutaneous Coronary Intervention)
Completed
- Coronary Artery Disease
- Percutaneous Coronary Intervention
-
Antwerp, Belgium
- +1 more
Jul 18, 2022
Coronary Artery Disease Trial (DES, DCB)
Not yet recruiting
- Coronary Artery Disease
- DES
- DCB
- (no location specified)
Feb 20, 2023
In-stent Restenosis Trial in Worldwide (Drug Eluting Balloon)
Active, not recruiting
- In-stent Restenosis
- Drug Eluting Balloon
-
Grenoble, France
- +8 more
Feb 7, 2023
Coronary Restenosis Trial in Ostrava (sirolimus-eluting balloon (SEB) MagicTouch, paclitaxel-eluting balloon (PEB) Sequent
Completed
- Coronary Restenosis
- sirolimus-eluting balloon (SEB) MagicTouch
- paclitaxel-eluting balloon (PEB) Sequent Please
-
Ostrava, CzechiaCardiovascular Department of University Hospital
Dec 6, 2022
Coronary Artery Disease Trial in Shenyang (Biolimus, Powerline)
Completed
- Coronary Artery Disease
- Biolimus
- Powerline
-
Shenyang, Liaoning, ChinaGeneral Hospital of Northern Theater Command
Sep 15, 2021
In-stent Restenosis and de Novo Coronary Lesions
Recruiting
- Coronary Heart Disease
- Pretreatment strategies before drug balloon therapy
- Different types of in-stent restenosis were treated with drug-coated balloons
-
Nanjing, Jiangsu, ChinaThe First Affiliated Hospital of Nanjing Medical University
Oct 24, 2022
Ischemic Heart Disease, Stenotic Coronary Lesion, Cardiovascular Diseases Trial in Shenyang, Beijing (Resolute Onyx™
Active, not recruiting
- Ischemic Heart Disease
- +4 more
- Resolute Onyx™ Zotarolimus-Eluting Coronary Stent System
- Resolute Integrity™ Zotarolimus-Eluting Coronary Stent System
-
Shenyang, Liaoning, China
- +1 more
Nov 2, 2022
Coronary Restenosis Trial (Magic Touch SCB by Concept Medical Inc.)
Not yet recruiting
- Coronary Restenosis
- Magic Touch SCB by Concept Medical Inc.
- (no location specified)
Jul 26, 2022
AV Fistula Trial in Athens, Patras (SELUTION SLR™ DEB, Control Arm)
Recruiting
- AV Fistula
- SELUTION SLR™ DEB
- Control Arm
-
Athens, Greece
- +2 more
Nov 10, 2022
Chronic Coronary Syndrome Trial (Magic Touch drug eluting balloon based strategy, Drug-eluting stent-based strategy)
Not yet recruiting
- Chronic Coronary Syndrome
- Magic Touch drug eluting balloon based strategy
- Drug-eluting stent-based strategy
- (no location specified)
Jan 5, 2023
Coronary Artery Disease, Myocardial Ischemia, Acute Coronary Syndrome Trial in Worldwide (SeQuent® Please NEO drug-coated
Not yet recruiting
- Coronary Artery Disease
- +4 more
- SeQuent® Please NEO drug-coated balloon catheter
- Current-generation drug-eluting stent
-
Chuncheon, Gangwon-do, Korea, Republic of
- +5 more
Apr 26, 2023
Coronary Artery Disease Trial (PCI)
Active, not recruiting
- Coronary Artery Disease
- PCI
-
Shengyang, Liaoning, ChinaGeneral Hospital of the PLA Northern Theater Command
Nov 2, 2022
Peripheral Arterial Disease Trial in Germany (Transluminal Angioplasty with Paclitaxel-coated Luminor® Balloon Catheter in the
Active, not recruiting
- Peripheral Arterial Disease
- Transluminal Angioplasty with Paclitaxel-coated Luminor® Balloon Catheter in the Superficial Femoral and Popliteal Arteries
- Transluminal Angioplasty with and non-coated (CE-marked) plain old angioplasty balloon (POBA) catheter
-
Karlsbad-Langensteinbach, Baden-Wuertemberg, Germany
- +10 more
Oct 19, 2022
Coronary Bifurcation Lesions Trial in Shanghai (Sirolimus Coated Balloon Catheter, a Paclitaxel Coated Balloon Catheter)
Recruiting
- Coronary Bifurcation Lesions
- Sirolimus Coated Balloon Catheter
- a Paclitaxel Coated Balloon Catheter
-
Shanghai, Shanghai, ChinaZhongshan Hospital, Fudan University
Aug 17, 2022
Coronary Artery Disease Trial in Nanjing (IVUS guidance, Angiography guidance)
Recruiting
- Coronary Artery Disease
- IVUS guidance
- Angiography guidance
-
Nanjing, Jiangsu, ChinaNanjing First Hospital
Jun 26, 2022
Coronary Artery Disease Trial in Kunming (Sirolimus-Eluting Iron Bioresorbable Coronary Scaffold System (IBS), Abbott Vascular
Recruiting
- Coronary Artery Disease
- Sirolimus-Eluting Iron Bioresorbable Coronary Scaffold System (IBS)
- Abbott Vascular XIENCE Everolimus Eluting Coronary Stent System
-
Kunming, ChinaFuwai Yunnan Cardiovascular Hospital
Mar 16, 2022
De Novo Stenosis, Coronary Artery Disease, Percutaneous Coronary Intervention Trial in Xi'an (Lepu Paclitaxel coated balloon,
Recruiting
- De Novo Stenosis
- +2 more
- Lepu Paclitaxel coated balloon
- +4 more
-
Xi'an, Shannxi, ChinaLing Tao
Jul 20, 2022
Coronary Artery Disease Trial in Novosibirsk (Drug coated balloon for the side brunch, Conventional balloon for the side brunch)
Recruiting
- Coronary Artery Disease
- Drug coated balloon for the side brunch
- Conventional balloon for the side brunch
-
Novosibirsk, Novosibirskaya Oblast, Russian FederationMeshalkin National Medical Research Center
Jan 23, 2022
Coronary Disease Trial in Beijing (Paclitaxel DCB, DES)
Completed
- Coronary Disease
- Paclitaxel DCB
- DES
-
Beijing, Beijing, ChinaBeijing Hospital
Mar 21, 2022
Coronary Arteriosclerosis Trial in China (OrbusNeich Combo stent™, sirolimus-eluting stent system)
Completed
- Coronary Arteriosclerosis
- OrbusNeich Combo stent™
- sirolimus-eluting stent system
-
Daqing, Heilongjiang, China
- +14 more
Sep 8, 2021
Drug-coated Balloon in de Novo Chronic Total Occlusions
Not yet recruiting
- Coronary Artery Disease
- Total Occlusion of Coronary Artery
- CTO PCI using DCB-only strategy
-
Čakovec, Croatia
- +15 more
Jul 28, 2023
Critical Limb Ischemia, Peripheral Arterial Disease Trial in Worldwide (DCB, PTA)
Active, not recruiting
- Critical Limb Ischemia
- Peripheral Arterial Disease
- DCB
- PTA
-
Dendermonde, East-Flanders, Belgium
- +9 more
Dec 21, 2021